Skip to main content

Abstract

The enkephalins can be cleaved by a variety of peptidases but it increasingly appears that two enzyme activities are mainly, if not solely, involved in their physiological inactivation (for reviews see Schwartz et al., 1981, 1982, 1983; Hui & Lajtha, 1983; Schwartz, 1983). The first, responsible for the cleavage of the Gly3-Phe4 amide bond of the opioid pentapeptides, is generally termed ‘enkephalinase’ (Malfroy et al., 1978). It is primarily associated with synaptic membranes (De La Baume et al., 1980) and is potently and selectively inhibited by Thiorphan® (Roques et al., 1980). Its inhibition allows an increased recovery of enkephalins released from striatal slices and, in vivo, a diminished responsiveness to various nociceptive stimuli (Patey et al., 1981; De La Baume et al., 1983; Chaillet et al., 1983a).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • ALGERI, S., ALTSTEIN, M., DE SIMONE, G.M. and GUARDABASSO, V. (1981). In vivo potentiation of (D-Ala2)met-enkephalin amide central effects after administration of an enkephalinase inhibitor. Eur. J. Pharmac., 74, 261–262.

    Article  CAS  Google Scholar 

  • ALMENOFF, J., WILS, S. and ORLOWSKI, M. (1981). Membrane bound pituitary metallo-endopeptidase: apparent identity to enkephalinase. Biochem. biophys. Res. Commun., 102, 206–214.

    Article  PubMed  CAS  Google Scholar 

  • ALTSTEIN, M., BLUMBERG, S. and VOGEL, Z. (1982). Phosphoryl-Leu-Phe: A potent inhibitor of the degradation of enkephalin by enkephalinase. Eur. J. Pharmac., 76, 299–300.

    Article  Google Scholar 

  • BEN NATAN, L., CHAILLET, P., LECOMTE, J-M., MARCAIS-COLLADO, H., HUCHIDA, G. and COSTENTIN, J. (1984). Involvement of endogenous enkephalins in the mouse ‘behavioral despair’ test. Eur. J. Pharmac., 97, 301.

    Google Scholar 

  • BÜNNING, P., HOLMQUIST, B. and RIORDAN, J.F. (1983). Substrate specificity and kinetic characteristics of angiotensin converting enzyme. Biochemistry, 22, 103–116.

    Article  PubMed  Google Scholar 

  • CHAILLET, P., MARCAIS-COLLADO, H., COSTENTIN, J., YI, C.C., DE LA BAUME, S. and SCHWARTZ, J-C. (1983a). Inhibition of enkephalin metabolism by, and antinociceptive activity of, bestatin, an aminopeptidase inhibitor. Eur. J. Pharmac., 86, 329–336.

    Google Scholar 

  • CHAILLET, P., MARCAIS-COLLADO, H. and COSTENTIN, J. (1983b). Catatonic or hypotonic immobility induced in mice by intracerebroventricular injections of mu and kappa opioid receptor agonists as well as enkephalins or inhibitors of their degradation. Life Sci., 33, 2105–2111.

    Google Scholar 

  • CHIPKIN, R.E., IORIO, L.C., BARNETT, A., BERGER, J. and BILLARD, W. (1982). In Regulatory Peptides: From Molecular Biology to Function. Costa, E. and Trabucchi, M. (eds) pp.235–242, New York: Raven Press.

    Google Scholar 

  • DE LA BAUME, S., PATEY, G. and SCHWARTZ, J-C. (1980). Subcellular distribution of enkephalin dipeptidylcarboxypeptidase (‘enkephalinase’) in rat brain. Neuroscience, 6, 315–321.

    Article  Google Scholar 

  • DE LA BAUME, S., YI, C.C., SCHWARTZ, J-C., CHAILLET, P., MARCAIS-COLLADO, H. and COSTENTIN, J. (1983). Participation of both ‘enkephalinase’ and aminopeptidase activities in the metabolism of endogenous enkephalins. Neuroscience, 8, 143–151.

    Google Scholar 

  • DESCHODT-LANCKMAN, M. and STROSBERG, D. (1983). In vitro degradation of the C-terminal octapeptide of cholecystokinin by enkephalinase A. FEBS Lett., 152, 109–113.

    Google Scholar 

  • ERDÖS, E.G., JOHNSON, A.R. and BOYDEN, N.T. (1978). Hydrolysis of enkephalin by cultured human endothelial cells and by purified peptidyl dipeptidase. Biochem. Pharmac., 27, 843–848.

    Article  Google Scholar 

  • FLORAS, P., BIDABÉ, A.M., CAILLÉ, J-M., SIMONNET, G., LECOMTE, J-M., & SABATHIE, M. (1983). Double-blind study of effects of enkephalinase inhibitor on adverse reactions to myelography. Am. J. Neuroradiology, 4, 653–655.

    Google Scholar 

  • FULCHER, I.S., MATSAS, R., TURNER, A.J. and KENNY, A.J. (1982). Kidney neutral endopeptidase and the hydrolysis of enkephalin by synaptic membrane show similar sensitivity to inhibitors. Biochem. J., 203, 519–522.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • HERSH, L.B. (1981). Solubilization and characterization of two rat brain membrane-bound aminopeptidases active on Met-enkephalin. Biochemistry, 20, 2345–2350.

    Article  PubMed  CAS  Google Scholar 

  • HUDGIN, R.L., CHARLESON, S.E., ZIMMERMAN, M., MUMFORD, R. and WOOD P.L. (1981). Enkephalinase: selective peptide inhibitors. Life Sci., 29, 2593–2601.

    Article  PubMed  CAS  Google Scholar 

  • HUI, K.S. and LAJTHA, A. (1983). In Handbook of Neurochemistry. Lajtha, E. (ed.) pp.1–19, New York: Plenum Publishing Corp.

    Book  Google Scholar 

  • HUI, K.S., WANG, Y.J. and LAJTHA, A. (1983). Purification and characterization of an enkephalin aminopeptidase from rat brain membranes. Biochemistry, 22, 1062–1067.

    Article  PubMed  CAS  Google Scholar 

  • INOKUCHI, J.I. and NAGAMATSU, A. (1981). Tripeptidyl carboxypeptidase activity of kininase II (angiotensin converting enzyme). Biochem. biophys. Res. Commun., 662, 300–307.

    CAS  Google Scholar 

  • KAYSER, V. and GUILBAUD, G. (1983). The analgesic effects of morphine but not those of the enkephalinase inhibitor, Thiorphan, are enhanced in arthritic rats. Brain Res., 267, 131–138.

    Article  PubMed  CAS  Google Scholar 

  • KENNY, A.J. (1977). In Proteinases in mammalian cells and tissues. Barrett, A.J. (ed.) pp. 393–444, Amsterdam: North-Holland.

    Google Scholar 

  • KORF, J., BUNNEY, B.S. and AGHAJANIAN, G.K. (1974). Noradrenergic neurons: morphine inhibition of spontaneous activity. Eur. J. Pharmac., 25, 165–169.

    Article  CAS  Google Scholar 

  • LLORENS, C., GACEL, G., SWERTS, J-P., PERDRISOT, R., FOURNIE-ZALUSKI, M.C., SCHWARTZ, J-C. and ROQUES, B.P. (1980). Rational design of enkephalinase inhibitors: substrate specificity of enkephalinase studied from inhibitory potency of various dipeptides. Biochem. biophys. Res. Commun., 96, 1710–1717.

    Article  PubMed  CAS  Google Scholar 

  • LLORENS, C., MARTRES, M-P., BAUDRY, M. and SCHWARTZ, J-C. (1978). Hypersensitivity to noradrenaline in cortex after chronic morphine: relevance to tolerance and dependance. Nature, 274, 603–605.

    Article  PubMed  CAS  Google Scholar 

  • LLORENS, C. and SCHWARTZ, J-C. (1984). Changes in turnover of cerebral monoamine following inhibition of enkephalin metabolism by Thiorphan and Bestatin. Eur. J. Pharmac. (in press).

    Google Scholar 

  • MALFROY, B. and SCHWARTZ, J-C. (1982). Properties of ‘enkephalinase’ from rat kidney: comparison of dipeptidyl-carboxypeptidase and endopeptidase activities. Biochem. biophys. Res. Commun., 106, 276–285.

    Article  PubMed  CAS  Google Scholar 

  • MALFROY, B., SWERTS, J-P., GUYON, A., ROQUES, B.P. and SCHWARTZ, J-C. (1978). High affinity enkephalindegrading peptidase in brain is increased after morphine. Nature, 276, 523–526.

    Article  PubMed  CAS  Google Scholar 

  • MALFROY, B., SWERTS, J-P., LLORENS, C. and SCHWARTZ, J-C. (1979). Regional distribution of a high-affinity enkephalin-degrading peptidase (‘enkephalinase’) and effects of lesions suggest localization in the vicinity of opiate receptors in brain. Neurosci. Lett., 11, 329–334.

    Article  PubMed  CAS  Google Scholar 

  • MATSAS, R., FULCHER, I.S., KENNY, A.J. and TURNER, A.J. (1983). Substance P and (Leu) enkephalin are hydrolysed by an enzyme in pig caudate synaptic membranes that is identical with the endopeptidase of kidney microvilli. Proc. natn. Acad. Sci. U.S.A., 80, 3111–3115.

    Article  CAS  Google Scholar 

  • MONTEL, H., STARKE, K. and WEBER, F. (1974). Influence of morphine and naloxone on the release of NA from brain cortex slices. Naunyn-Schmiedebergs Arch. Pharmac., 283, 357–359.

    Article  CAS  Google Scholar 

  • MUMFORD, R.A., ZIMMERMAN, M., BROEKE, J.T., TAUB, D., JOSHUA, H., ROTHROCK, S.W., HIRSHFIELD, J.M., SPRINGER, J.P. and PATCHETT, A.A. (1982). Inhibition of porcine kidney ‘enkephalinase’ by substituted-D-carboxymethyl dipeptides. Biochem. biophys. Res. Commun., 109, 1303–1309.

    Article  PubMed  CAS  Google Scholar 

  • PATEY, G., DE LA BAUME, S., SCHWARTZ, J-C., GROS, C., ROQUES, B.P., FOURNIE-ZALUSKI, M.C. and SOROCALUCAS, E. (1981). Selective protection of methionine enkephalin released from brain slices by enkephalinase inhibition. Science, 212, 1153–1155.

    Google Scholar 

  • ROQUES, B.P., FOURNIE-ZALUSKI, M.C., SOROCA, E., LECOMTE, J-M., MALFROY, B. and SCHWARTZ, J-C. (1980). The enkephalinase inhibitor. Thiorphan shows antinociceptive activity in mice. Nature, 288, 286–288.

    Google Scholar 

  • SCHWARTZ, J-C. (1983). Metabolism of enkephalins and the concept of neuropeptidase. Trends Neurosci., 6, 15–18.

    Google Scholar 

  • SCHWARTZ, J-C., DE LA BAUME, S., YI, C.C., CHAILLET, P., MARCAIS-COLLADO, H. and COSTENTIN, J. (1982). Enkephalin metabolism in brain and its inhibition. Prog. Neuro. Psych., 6, 665–671.

    Google Scholar 

  • SCHWARTZ, J-C., DE LA BAUME, S., YI, C.C., CHAILLET, P., MARCAIS-COLLADO, H. and COSTENTIN, J. (1983). Peptidases involved in the inactivation of exogenous and endogenous enkephalins. J. Neural trans., 18, 235–243.

    Google Scholar 

  • SCHWARTZ, J-C., GROS, C., GIROS, B., LLORENS, C., MALFROY, B., ROSE, C. and ZUZEL, K. (1984). Metabolic inactivation of enkephalins. Proceedings of the 5th Meeting of the Eur. Soc. Neurochem. Amsterdam: Elsevier Publishers (in press).

    Google Scholar 

  • SCHWARTZ, J-C., MALFROY, B. and DE LA BAUME, S. (1981). Biological inactivation of enkephalins and the role of enkephalin dipeptidyl carboxypeptidase (‘enkephalinase’) as neuropeptidase. Life Sci., 29, 1715–1740.

    Article  PubMed  CAS  Google Scholar 

  • SCHWARTZ, J-C., POLLARD, H., LLORENS, C., MALFROY, B., GROS, C., PRADELLES, P. and DRAY, F. (1978). In Advances in biochemical psychopharmacology. Costa, E. and Trabucchi, M. (eds) pp. 245–264, New York: Raven Press.

    Google Scholar 

  • UMEZAWA, H., AOYAGI, T., SUDA, H., HAMADA, M. and TAKEUCHI, T. (1976). Bestatin, an inhibitor of aminopeptidase B, produced by actinomycetes. J. Antibiotics, 29, 97–99.

    Article  CAS  Google Scholar 

  • WOOD, P.L. (1982). Phasic enkephalinergic modulation of nigrostriatal dopamine metabolism: potentiation with enkephalinase inhibitors. Eur. J. Pharmac., 82, 119–120.

    Article  CAS  Google Scholar 

  • YAKSH, T.L. and HARTY, G.M. (1982). Effects of thiorphan on the antinociceptive actions of intrathecal (DA1a2, Met5) enkephalin. Eur. J. Pharmac., 79, 293–300.

    Article  CAS  Google Scholar 

  • ZHANG, A.Z., YANG, H.Y.T. and COSTA, E. (1982). Nociception, enkephalin content and dipeptidyl carboxypeptidase activity in brain of mice treated with exopeptidase inhibitors. Neuropharmacology, 21, 625–630.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

William Paton James Mitchell Paul Turner Cheryl Padgham Eileen Ashcroft

Copyright information

© 1984 Macmillan Publishers Limited

About this chapter

Cite this chapter

Schwartz, J.C., Giros, B., Gros, C., Llorens, C., Malfroy, B. (1984). Metabolism of enkephalins and its inhibition. In: Paton, W., Mitchell, J., Turner, P., Padgham, C., Ashcroft, E. (eds) IUPHAR 9th International Congress of Pharmacology London 1984. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-349-17615-1_40

Download citation

Publish with us

Policies and ethics